Digital Thesis Room >
Faculty of Graduate Studies >
Theses & Dissertations >
Please use this identifier to cite or link to this item:
|Title: ||Associations between essential medicine listing and health outcomes for cardiovascular disease|
|Authors: ||Liane, Steiner|
|Supervisor(s): ||Dr. Shawn Fraser
Dr. Navindra Persaud
University of Toronto|
|Examining Committee: ||Dr. F. Haider Alvi Athabasca University|
|Degree: ||Master of Health Studies|
|Department: ||Faculty of Health Disciplines|
|Keywords: ||cardiovascular disease|
|Issue Date: ||28-Jul-2020|
|Abstract: ||Context: National essential medicines lists are used to guide medicine selection, appropriate use, medicine reimbursement and public sector medicine procurement for many countries therefore medicine listings may impact health outcomes.
Methods: Countries’ national essential medicine lists were scored on whether they listed medicines for ischemic heart disease, cerebrovascular disease and hypertensive heart disease was synthesized. Linear regression was used to measure the association between countries’ medicine coverage scores and healthcare access and quality scores.
Results: There was no association between medicine coverage scores and healthcare access and quality scores when country characteristics were accounted for. However, there was an association between health outcome scores and health expenditure for ischemic heart disease, cerebrovascular disease and hypertensive heart disease.
Conclusion: Listing more medicines on national essential medicine lists may not improve health access and quality scores; rather it may only be one factor in reducing mortality from cardiovascular disease.|
|Graduation Date: || -1|
|Appears in Collections:||Theses & Dissertations|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.